28 Feb 2023 by admin in UncategorizedComments Oricell Closes $45M Series B1 Financing to Expand Development of Key Products
28 Feb 2023 by admin in UncategorizedComments Eluminex Biosciences Closes $40+ Million Series B Financing
14 Feb 2023 by admin in UncategorizedComments Eluminex Announces Completion of Enrollment in Part A of the CLARITY Study
31 Jan 2023 by admin in UncategorizedComments Oricell Publishes Data from POLARIS Clinical Study Evaluating OriCAR- 017 in the Treatment of RRMM
31 Jan 2023 by admin in UncategorizedComments Crescendo Biologics is category winner for Biopharma and Vaccines in 2023 UK DIT Life Sciences Innovator Showcase
26 Jan 2023 by admin in UncategorizedComments Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Higher-Risk Myelodysplastic Syndrome
20 Dec 2022 by admin in UncategorizedComments Kira Pharmaceuticals Announces Clearance to Initiate Phase 2 Evaluation of KP104 in IgA Nephropathy (IgAN) and Complement 3 Glomerulopathy (C3G) in China and Australia
09 Dec 2022 by admin in UncategorizedComments Arcellx And Kite Announce Strategic Collaboration To Co- Develop And Co-Commercialize Late-Stage Clinical CART- DdBCMA In Multiple Myeloma
